IP Verse

Treatment Comprising Oral Or Gastric Administration Of Edaravone - EP3551181

The patent EP3551181 was granted to Treeway TW on Nov 18, 2020. The application was originally filed on Jan 17, 2018 under application number EP18701303A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP3551181

TREEWAY TW
Application Number
EP18701303A
Filing Date
Jan 17, 2018
Status
Opposition Rejected
Nov 10, 2023
Grant Date
Nov 18, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

BARDEHLE PAGENBERG PARTNERSCHAFT MBB PATENTANWALTEAug 18, 2021 -

Patent Citations (14) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONCN101953832
DESCRIPTIONCN105816423
DESCRIPTIONEP1405637
DESCRIPTIONEP1714960
DESCRIPTIONEP2754440
DESCRIPTIONWO2012019381
INTERNATIONAL-SEARCH-REPORTCN102349893
OPPOSITIONCN102349893
OPPOSITIONEP1714960
OPPOSITIONJP2004002400
OPPOSITIONJP2009143922
OPPOSITIONJP2009155315
OPPOSITIONJP2009280561
OPPOSITIONJP2010077104

Non-Patent Literature (NPL) Citations (7) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Anonymous, "RADICUT® BAG for I.V. Infusion 30 mg", Mitsubishi Tanabe Pharma Corporation, (20161201), pages 1 - 8, XP055837892-
OPPOSITION- Bundle of Exhibits O12-
OPPOSITION- MITSUBISHI TANABE PHARMA CORPORATION, "Radicut In- jection 30 mg", INTERNET CITATION, (20150601), pages 1 - 6, XP002777674-
OPPOSITION- Russ Kirk B, Et Al, "Percutaneous Endoscopic Gastrostomy in Amyotrophic Lateral Sclerosis", The American Journal of the Medical Sciences, (20150801), pages 95 - 97, The American Journal of the Medical Sciences, URL: https://www.amjmedsci.com/article/S0002-9629(15)41236-4/fulltext, (20210906), XP055837900-
OPPOSITION- PARIKH ANKIT et al., "Development of a novel oral delivery sys- tem of edaravone for enhancing bioavailability", INTERNA- TIONAL JOURNAL OF PHARMACEUTICS, KIDLINGTON, (20161024), vol. 515, pages 490 - 500, XP002770642
OPPOSITION- ISHIZAWA M et al., "An antioxidant treatment potentially pro- tects myocardial energy metabolism by regulating uncoupling ]\pro- tein 2 expression in a chronic beta-adrenergic stimulation rat model", LIFE SCIENCES, OXFORD, GB, (20060515), vol. 78, no. 25, pages 2974 - 2982, XP028050767
OPPOSITION- SHU-SHENG JIAO et al., "Edaravone alleviates Alzheimer's dis- ease-type pathologies and cognitive deficits", PROCEEDINGS NA- TIONAL ACADEMY OF SCIENCES PNAS, (20150406), vol. 112, no. 16, pages 5225 - 5230, XP055445120

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents